Drug Manufacturer Coupons: Charitable Assistance or Marketing Tool?
Drug Topics
MAY 31, 2023
The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.
Wed.May 31, 2023
186 
Clinical Overview: Biologic Agents for the Treatment of Crohn Disease
Pharmacy Times
MAY 31, 2023
As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Support your Pharmacy’s Just Culture Journey
Drug Topics
MAY 31, 2023
Pharmapod’s Incident Management reporting platform + Patient Safety Organization improves processes to enhance medication and patient safety
Questionable Drug Studies in Minors Enforced by Regulatory Authorities
Pharmacy Times
MAY 31, 2023
Pediatric drug development, which has a complex background and history, has fundamental catches based around how children are defined in the context of clinical studies.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
ASCO: Novartis pressures Lilly with Kisqali, targeting $3B opportunity in early breast cancer
Fierce Pharma
MAY 31, 2023
Adding Kisqali to endocrine therapy after surgery reduced the risk of invasive tumor recurrence or death by 25% in certain early-stage breast cancers.
RFID is the Future of Hospital Efficiency: Here’s Why You Should Get Involved
Pharmacy Times
MAY 31, 2023
Radio frequency identification-enabled automation for inventory management has only achieved its massive adoption in the retail space over the past 2 decades.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
Pharmaceutical Technology
MAY 31, 2023
XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will receive $250m in upfront and milestone payments. The two companies will use XtalPi’s integrated AI capabilities and robotics platform for the de novo [without consideration of previous instances] design and delivery of drug candidates for an undisclosed target.
Employers hope to weather inflation without shifting healthcare costs to workers: survey
Fierce Healthcare
MAY 31, 2023
Employers are bracing for 2024, fearing they’ll face inflation and soaring healthcare costs while still trying to recruit and retain workers in a tight labor market, a new survey shows. | Employers got something of a break last year from inflation when it comes to healthcare costs because most contracts with providers last three years. A survey by the consulting company Mercer says they won’t be so lucky in 2024.
Former Novartis execs cleared of Greek bribery charges after yearslong investigation
Fierce Pharma
MAY 31, 2023
After a yearslong investigation involving politicians and medical professionals alike, Novartis is looking to close the books on its Greek bribery imbroglio. | After an investigation that dates back to 2017, four former Novartis executives and a Greek politician were cleared of bribery charges. But 15 doctors were charged for their alleged involvement.
Patients, providers still see many pain points with 'digital front door' and care access, survey finds
Fierce Healthcare
MAY 31, 2023
Despite the increased adoption of digital health tools and telehealth in the past three years, patients and providers see the "digital front door" as still being a less-than-ideal entry point into | More than a quarter of patients believe the payment experience has gotten worse. Four in 10 patients said they’re likely to cancel or postpone care without an accurate cost estimate.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy
Fierce Pharma
MAY 31, 2023
FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy kdunleavy Wed, 05/31/2023 - 13:02
Hospital operating margins break even in April, though Medicaid redeterminations are looming
Fierce Healthcare
MAY 31, 2023
Hospitals’ year-to-date operations broke even in April, though a rise in bad debt and a dip in volumes suggest the upward momentum will likely be short-lived, healthcare consulting firm Kaufman Hal | Kaufman Hall's latest monthly industry report showed a 0% year-to-date median operating margin across the hospital industry as well as signs of bad debt and charity care beginning to pick up as states begin paring their Medicaid populations.
FDA Approves Imaging Agent With Radiohybrid Technology to Identify Location, Extent of Prostate Cancer
Pharmacy Times
MAY 31, 2023
The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate.
Walmart rolling out new training program for vision center staff
Fierce Healthcare
MAY 31, 2023
BENTONVILLE, Arkansas—Retail giant Walmart will roll out a new program that aims to assist employees of its vision centers in advancing their careers. | Retail giant Walmart will roll out a new program that aims to assist employees of its vision centers in advancing their careers.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA approves Pfizer’s RSV vaccine for older adults
STAT
MAY 31, 2023
The Food and Drug Administration approved a second vaccine to protect older adults against RSV on Wednesday, giving a green light to Pfizer’s Abrysvo for adults 60 and older. Early in May the FDA approved the first ever vaccine against respiratory syncytial virus, or RSV, when it licensed GSK’s Arexvy.
Big Pharma inventory management trends revealed
European Pharmaceutical Review
MAY 31, 2023
The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer. It investigated how excessive inventories are affecting the industry and what factors could influence inventory growth in 2023.
Opinion: Listen: Ezekiel Emanuel explains why cancer patients shouldn’t pay out-of-pocket costs
STAT
MAY 31, 2023
The high cost of cancer treatment in the U.S. is literally killing people. “Over a quarter of cancer patients delay medical care , go without care, or make changes in their cancer treatment because of cost,” Ezekiel Emanuel, an oncologist and co-director of the Health Care Transformation Institute at the University of Pennsylvania, wrote in a recent First Opinion essay.
Walgreens celebrates Clinical Trials Day
Drug Store News
MAY 31, 2023
The Walgreens Clinical Trials team brought together industry professionals and community members to talk about the advances and challenges in the clinical trials space.
Opinion: Newly diagnosed cancer patients need help navigating the system
STAT
MAY 31, 2023
“Hey, I’m sorry to bother you, but I could really use your advice on something.” As fellows in oncology training programs, we’re both accustomed to fielding texts, emails, and calls that start out like the above from family, friends, and acquaintances seeking guidance for themselves or their loved ones after a cancer diagnosis.
NHS workforce plan further delayed over cost concerns
Hospital Pharmacy Europe
MAY 31, 2023
The Government’s long-awaited NHS workforce plan appears to have been delayed as rumours circulate that it is too expensive. According to deputy chief executive of NHS Providers Saffron Cordery, the plan, which was expected for publication on 30 May, has been delayed further. Speaking on BBC Radio 4’s Today programme, Ms Cordery said the plan will require ‘a very significant commitment of funding’ from the Government.
STAT+: CVS warns PBM reforms ‘could lead to higher costs’
STAT
MAY 31, 2023
As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health, which owns one of the largest PBMs in the country, said the company would find ways to maintain its level of profit if those reforms to things like drug rebates went into effect. “There’s other ways in the economic model that we can adjust to if one of those things changes,” Shawn Guertin, CVS’ chief financial officer, said at an industry conference Wednesday.
Stealth and Pharmanovia partner for commercialisation of elamipretide
Pharmaceutical Technology
MAY 31, 2023
Stealth BioTherapeutics has made an exclusive licensing agreement with Pharmanovia for the commercialisation of its elamipretide to treat Barth syndrome. Pharmanovia will hold exclusive rights for the commercialisation of elamipretide in the EU, other European countries including Switzerland, Norway, Iceland and the UK, and the Middle East and northern Africa region.
STAT+: Pharmalittle: Appeals court rules Purdue can shield Sacklers from lawsuits; chemo shortage blamed on drugmakers’ lack of investment
STAT
MAY 31, 2023
Hey there. STAT reporter Andrew Joseph here welcoming you to Wednesday’s edition of Pharmalittle, with Pharmalot himself off for the day. We’re based here in London, so instead of firing up another cup of stimulation, we’re more focused on what post-lunch snack awaits us. As we ponder, we’ll leave you with the latest headlines.
Dollar General announces promotions, new appointment
Drug Store News
MAY 31, 2023
The retailer has promoted several officers across its Store Support Center and Field teams and appointed a new leader of inventory teams for its consumables business.
Algiax Pharmaceuticals 'convinced' they can provide new treatment for chronic pain relief
Outsourcing Pharma
MAY 31, 2023
A small molecule drug candidate from Algiax Pharmaceuticals can reduce excitability of neurons in relation to chronic pain, dampening signal and reducing pain, a study shows.
How amitriptyline can help anxious dogs
The Checkup by Singlecare
MAY 31, 2023
Though we often think of dogs as leading happy, carefree lives, some feel distressed to the point of causing self-harm, property damage, or bad behavior. We want our pets to be happy and healthy, so we need ways to teach them to feel safe and secure. Many pet parents medicate their animals with antidepressants or anti-anxiety medications to help the entire household run more harmoniously.
CRISPR-based microbial gene therapy delivers promise
European Pharmaceutical Review
MAY 31, 2023
The novel CRISPR-Cas therapeutic selectively targets antibiotic-resistant E. coli which can cause life-threatening bloodstream infections” Positive interim results from a Phase I trial have demonstrated that the first CRISPR-armed phage microbial gene therapy can reduce Escherichia coli ( E. coli ) levels in the GI tract. “With the combined killing effects of bacteriophages and CRISPR-Cas technology, SNIPR001 has demonstrated the ability to target and eliminate antibiotic-resistant E
Giant Food taking precautions to stop theft in stores
Drug Store News
MAY 31, 2023
Giant Food plans to limit the number of entrances to stores to create more obstacles for shoplifters and also hire security guards.
Woman of the Week: Mirati Therapeutics’ Laurie Stelzer
PharmaVoice
MAY 31, 2023
With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial-based organization.
ASCO 2023 preview: Prioritising the exploration of patient differences to enhance cancer care and research
pharmaphorum
MAY 31, 2023
ASCO 2023 preview: Prioritising the exploration of patient differences to enhance cancer care and research Mike.
US appeal in high-stakes Gilead patent case garners support from patient advocates
Fierce Pharma
MAY 31, 2023
Weeks after Gilead Sciences prevailed over the U.S. government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ push to appeal. | Weeks after Gilead Sciences prevailed over the U.S. government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ push to appeal.
PM Society’s ‘Securing Market Access to Medicines for England, Ireland, Scotland & Wales’ – part one
pharmaphorum
MAY 31, 2023
PM Society’s ‘Securing Market Access to Medicines for England, Ireland, Scotland & Wales’ – part one Mike.
FDA Grants Priority Review to Repotrectinib for Non-Small Cell Lung Cancer
Pharmacy Times
MAY 31, 2023
Repotrectinib is a promising next-generation tyrosine kinase inhibitor under investigation for the treatment of ROS1-positive locally advanced or metastatic non-small cell lung cancer.
Kaiser Permanente pledges up to $10M to struggling Colorado safety net system
Fierce Healthcare
MAY 31, 2023
Kaiser Permanente opened its wallet for a $10 million commitment to support a financially struggling Colorado safety net system, according to a Tuesday announcement. | Denver Health, which cares for a third of the city's residents, has faced rising expenses and an influx of patients in need of charity care.
Let's personalize your content